Propanc Biopharma, Inc.
PPCBNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $383.75K
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.16$6.79
- Volume (live)
- -
- Avg. volume (3M)
- 351.67K
Propanc Biopharma (PPCB) Stock Price & Financial Analysis
Propanc Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.33 - $0.40 |
|---|---|
| 52-Week High | $6.79 |
| 52-Week Low | $0.16 |
| Open | $0.35 |
| Volume (last close) | 2.05M |
| Average Volume (3M) | 351.67K |
| 50-Day MA | $0.89 |
|---|---|
| 200-Day MA | $1.69 |
| 1-Year Change | −78.39% |
| Market Cap | 383.75K |
|---|---|
| Shares Outstanding | 1.12M |
| Price to Book (P/B) | 0.04 |
| EV/EBITDA | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Propanc Biopharma at a Glance
As of the Oct 16, 2026 close, Propanc Biopharma (PPCB) has a market capitalization of $383.75K.
As of its latest reported balance sheet, it holds $832.01K in cash and securities against $509.12K of debt, a net cash position of $322.89K.
Propanc Biopharma does not currently pay a dividend.
The share price is down 78.4% over the past year. At $0.34 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.16 to $6.79, below its 200-day moving average of $1.69.
Frequently Asked Questions About Propanc Biopharma
What is the current stock price for PPCB?
As of the Oct 16, 2026 close, PPCB stock trades at $0.34. The 52-week range is $0.16–$6.79, with a day range of $0.33–$0.40.
What is the P/E ratio for PPCB?
The P/E ratio (Price-to-Earnings) for PPCB is shown in the Key Statistics section. This valuation metric helps compare Propanc Biopharma, Inc. to industry peers.
Does PPCB pay dividends?
Propanc Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PPCB?
Analyst ratings and recommendations for PPCB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PPCB?
As of the Oct 16, 2026 close, Propanc Biopharma's market capitalization is $384,308.478, classifying it as a micro-cap company. Propanc Biopharma operates in the Healthcare sector within the Biotechnology industry.